Canopy Growth (NASDAQ: CGC ) rallied 24% on Monday as President Trump announced that his administration would consider rescheduling cannabis over the next few weeks. Canopy Growth via Canopy USA is firmly positioned to expand into US cannabis markets. Canadian LPs andWelcome to the home of The Cannabis Report: a monthly report on the cannabis industry. I am an analyst and consultant in the cannabis industry. I have contributed to High Times Magazine. I currently have a book out, Cannabis in the Ancient Gree ...

Top Cannabis Companies For Marijuana Stock InvestorsNow that the focus for marijuana stocks is long-term investing, what are those who want profits now to do? Well, the short answer is that people can only control the market to a certain extent, yet in this case, it’s day by day, even with a fall in overall value for the cannabis industry in the USA, along with the fall in trading for most pot stocks.Still, the industry survives in volatile waves and gives more reasons to stay in the game. Consumer demand w ...

Slightly Stoopid Talks Cannabis: ‘Props From Wu-Tang’ And A Strain Named After A Song https://t.co/b3p1hXFMl8 https://t.co/b3p1hXFMl8 ...

Core Viewpoint - Herbal Dispatch Inc. is planning a non-brokered private placement to raise up to $1,000,000, which will support its anticipated export growth and working capital needs [1][2]. Group 1: Private Placement Details - The company intends to issue up to 20,000,000 units at a price of $0.05 per unit, with each unit consisting of one common share and one-half common share purchase warrant [1]. - Each full warrant can be exercised for one common share at a price of $0.08 per share for a period of 24 months after the closing date [1]. - The closing of the private placement is expected before August 29, 2025, and is subject to regulatory approvals [3]. Group 2: Use of Proceeds - Proceeds from the private placement will be utilized for working capital to support the company's expected export growth [2]. Group 3: Company Overview - Herbal Dispatch operates leading cannabis e-commerce platforms and aims to provide high-quality cannabis products at affordable prices [4]. - The company's flagship marketplace, herbaldispatch.com, offers exclusive access to small-batch craft cannabis and various product formats [4].

Core Insights - Greenway Greenhouse Cannabis Corporation reported a significant 71% increase in annual revenue for the year ended March 31, 2025, reaching CAD 8,948,943, with a remarkable 107% growth in the fourth quarter [1][5] - The average selling price of cannabis rose by 40% year-over-year to CAD 1.32 per gram, with the fourth quarter average at CAD 1.46 per gram, indicating strong brand strength and premium product positioning [1][5] - The company transitioned from a cash burn to generating net cash of CAD 1.8 million from operating activities, marking a pivotal shift in financial health [1][5] Financial Performance - The total grams sold during the fiscal year amounted to 6,803,628, reflecting a 23% increase year-over-year [5] - Adjusted EBITDA for the year was CAD 1,181,419, a significant improvement from a negative adjusted EBITDA of CAD 624,391 in the previous year [5][7] - The company achieved a net income of CAD 202,729 in the fourth quarter, showcasing a turnaround in profitability [5] Operational Metrics - The average cash cost per gram sold was CAD 0.83, with a reduced cost of CAD 0.73 in the fourth quarter, indicating improved operational efficiency [5] - Working capital, excluding amounts due to related parties, increased to CAD 3,997,814 as of March 31, 2025, compared to CAD 3,283,911 the previous year [5] - The cash balance rose by CAD 1,612,088 to CAD 3,142,898 over the fiscal year, reflecting enhanced liquidity [5]

Legal & Regulatory - Cannabis farmer caught with £96 thousand plant haul [1]

Industry Focus - The cannabis industry is exploring innovative flavor profiles and product development, similar to Willy Wonka's factory [1] Market Trends - The article highlights the creative and experimental nature of cannabis product development [1]

Core Viewpoint - The Story dispensary in Hoboken is resuming construction after a prolonged period of controversy and litigation, with concerns from local residents regarding its impact on the neighborhood [3][5][6]. Group 1: Background and Controversy - The Story dispensary has faced significant opposition over the past four years, including a court settlement and a petition from neighbors concerned about increased traffic [3][4]. - The dispensary's location has raised questions about potential conflicts of interest due to its ties to local politicians, particularly Mayor Steven Fulop [5][8]. - Residents initially believed the location would be used for physical therapy, leading to a lawsuit that was settled last year [6]. Group 2: Regulatory and Operational Status - Despite ongoing construction, the Story dispensary does not currently have the necessary permits to operate, putting the project at risk [9]. - The state has recently approved licenses for cannabis consumption lounges, but only a few locations have been authorized for this use so far [10]. Group 3: Community Perspectives - Some community members argue that the dispensary will not negatively impact the area more than existing bar-restaurants [7]. - A petition has been initiated by residents who believe the dispensary is poorly located [7].

Core Insights - Pure Sunfarms Corp. has published significant research on THC potency variability in cannabis, emphasizing the need for improved labeling practices in the industry [1][3][4] Group 1: Research Findings - The study conducted by Village Farms Canadian Cannabis Research analyzed dried cannabis flower from commercial-scale production, revealing substantial THC level variations within individual plants and across different strains [2] - The research indicates that cannabis, being an agricultural product, exhibits natural variability influenced by environmental factors, challenging the notion of a fixed THC percentage as a quality measure [3] Group 2: Industry Implications - Current Canadian regulations require a single THC percentage on cannabis packaging, which the study suggests misrepresents the actual cannabinoid content experienced by consumers [3] - The findings provide a basis for evidence-based policy discussions and potential regulatory changes in the cannabis industry [3] Group 3: Company Overview - Pure Sunfarms is a leading cannabis producer in Canada, operating one of the largest cannabis facilities globally, with a focus on high-quality B.C. grown cannabis [5][8] - The company is recognized for its popular cultivars, including Pink Kush, and maintains EU GMP certification for international medicinal market exports [6][8] Group 4: Future Growth and Expansion - Village Farms, the parent company of Pure Sunfarms, is expanding its cannabis operations internationally, targeting markets with significant growth potential and exporting medical cannabis to countries like Germany and Australia [9] - The company also plans to enter the U.S. THC market, leveraging its greenhouse assets in Texas for future expansion [10]

Industry Overview - Cannabis legalization in Thailand in 2022 provided crucial support for rural farmers [1] Regulatory Uncertainty - The Thai government is now reversing its cannabis legalization policy, creating uncertainty for farmers [1] Economic Impact - The future of rural farmers who relied on cannabis as a lifeline is now unclear [1]